Searching for weight loss injection deals? Here's what you actually need to know

You've seen the prices. Some of them look very different from others.

Say you've spent twenty minutes comparing websites. One clinic quotes £199 a month, another £349, a third is vague about it entirely. A fourth has a discount code in a social media ad. It's genuinely confusing, and it's not a sign you're missing something obvious, the market for private weight-loss injections in the UK became crowded very quickly after these medicines became headline news, and pricing is all over the place.

Here's the thing that makes comparison difficult: the medicines themselves are the same wherever you get them (assuming a legitimate supply chain), but what surrounds them varies enormously. Some headline prices include the consultation and the prescription; others don't. Some include delivery; others charge separately. Some offer ongoing clinical review before every repeat order; others are effectively self-service after the first month. When you strip away what's included, a higher-looking monthly figure sometimes costs less in practice than one that looks cheaper on a landing page.

The full picture on what drives private treatment costs is worth reading before you commit anywhere, it explains what to ask every provider before you hand over card details. One question that tends to catch people out: is a clinical re-review included before each repeat, or does the prescription renew automatically? Under GPhC guidance, every repeat order at a properly run pharmacy should receive a fresh clinical check.

What makes a seller a red flag, not a bargain

The MHRA has been unambiguous about this: buying weight-loss medicines without a valid prescription from a registered pharmacy carries real risks. In October 2023 the first major public warnings came after counterfeit pens (some containing insulin rather than the labelled medicine) were seized in the UK. Enforcement has escalated since: around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million were seized during 2025, and the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided in Northampton in October 2025. The MHRA's Yellow Card scheme lets you report both suspected side effects and suspect sellers, worth bookmarking.

The red flags to watch for: sellers offering Mounjaro or Wegovy without any consultation process, social-media accounts advertising pens for direct purchase, prices significantly below the £149 floor seen in the legitimate market, and "discount codes" tied to specific medicines from accounts you can't verify. Discount codes attached to prescription medicines from unverified sellers aren't a saving, they're a warning sign. Any genuine UK pharmacy dispensing these medicines can be checked on the GPhC pharmacy register; if a seller isn't listed, that's your answer.

Worth saying plainly: none of this means every affordable private service is unsafe, or that spending more guarantees better care. It means the right question isn't "who is cheapest" but "what am I actually getting for this price."

What the UK trials showed (and why clinical oversight is part of how the medicine works

The results from the SURMOUNT-1 trial) which studied tirzepatide in thousands of adults with obesity over 72 weeks, showed average body-weight reductions of around 20–21% at the highest dose. The STEP 1 trial for semaglutide 2.4mg (Wegovy) showed around 15% average reduction over 68 weeks. Both trials were conducted alongside dietary support and increased activity, and participants were closely monitored throughout. You can read the UK-relevant trial evidence if you want the full picture.

The reason clinical oversight matters here isn't bureaucratic box-ticking. Titration (starting low and increasing the dose gradually) is central to how these medicines work and how side effects (mostly gastrointestinal: nausea, loose stools, reflux, fatigue in the early weeks) are managed. A prescriber who reviews your progress before each dose step is doing something the medicine actually requires; it's not an optional extra you should feel comfortable skipping to save money. The NHS tirzepatide medicines page describes this in plain language if you'd like a starting point.

If you're currently on treatment elsewhere and thinking about switching providers (perhaps because costs have changed, or because aftercare has felt thin) the process for a transfer is straightforward with a regulated service. Your current dose and evidence of treatment are reviewed before anything changes.

Timing, cost, and how to approach a repeat-order budget

One thing that catches people off guard: these medicines are titrated over months, which means the cost changes as the dose increases. Starting at 2.5mg (the tolerability dose, giving your system time to adjust) is cheaper per pen than maintaining at 10mg or 15mg. That makes budgeting slightly more involved than a flat monthly subscription, and it's worth factoring in when you first look at any price list. Some people plan their first order around payday, or start in January when routines feel fresh; either works, but the more useful question is whether the service you're using will still be giving you proper clinical oversight six months in, at a higher dose, rather than what the first pen costs.

There is no legitimate shortcut to a lower price on these medicines through discount codes, flash sales or promotional offers. Eli Lilly raised Mounjaro's UK list price from 1 September 2025, and that cost sits in every legitimate supply chain. What can vary is how much additional value a service wraps around it. At nume, one price covers the consultation, the prescription, the medicine, free next-working-day DPD delivery and 7-day aftercare, no subscription, no auto-renewal, and a real prescriber reviews your case before every repeat. We're not positioned as the cheapest option, and that's deliberate. If you'd like to understand exactly what's involved before committing to anything, speaking to our prescribers through a free consultation is the place to start, no obligation, and the clinical assessment happens the same day.

For a broader look at the injections themselves before you decide, the overview of weight-loss injection options covers how Mounjaro and Wegovy compare at a practical level. And if you're wondering whether you'd qualify, if you want to understand how a weight loss injection fits into a broader treatment plan, or want to compare 3 weight loss injections side by side before making a decision, the GP and private eligibility guide lays out the criteria clearly.